Cargando…

JNK2 downregulation promotes tumorigenesis and chemoresistance by decreasing p53 stability in bladder cancer

Bladder cancer is one of the most common malignancies of the urinary system, and the 5-year survival rate remains low. A comprehensive understanding of the carcinogenesis and progression of bladder cancer is urgently needed to advance treatment. c-Jun N-terminal kinase-2 (JNK2) exhibits both tumor p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Chun-Wu, Liu, Hailong, Zhao, Yu, Qian, Chenchen, Wang, Liguo, Qi, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085214/ https://www.ncbi.nlm.nih.gov/pubmed/27147566 http://dx.doi.org/10.18632/oncotarget.9046

Ejemplares similares

Downregulation of CPT2 promotes tumorigenesis and chemoresistance to cisplatin in hepatocellular carcinoma
por: Lin, Meihua, et al.
Publicado: (2018)

MEX3C regulates lipid metabolism to promote bladder tumorigenesis through JNK pathway
por: Chao, Haichao, et al.
Publicado: (2019)

Girdin Promotes Tumorigenesis and Chemoresistance in Lung Adenocarcinoma by Interacting with PKM2
por: Cao, Fuyang, et al.
Publicado: (2022)

Loss of the emei tumor suppressor promotes tumorigenesis via the JNK and Hippo pathway
por: Yang, Shuai, et al.
Publicado: (2022)

Chitinase 3 like 1 suppresses the stability and activity of p53 to promote lung tumorigenesis
por: Park, Kyung-Ran, et al.
Publicado: (2020)

USP32 promotes tumorigenesis and chemoresistance in gastric carcinoma via upregulation of SMAD2
por: Dou, Ning, et al.
Publicado: (2020)

TEX10 Promotes the Tumorigenesis and Radiotherapy Resistance of Urinary Bladder Carcinoma by Stabilizing XRCC6
por: Luo, Sheng, et al.
Publicado: (2021)

A novel mutant p53 binding partner BAG5 stabilizes mutant p53 and promotes mutant p53 GOFs in tumorigenesis
por: Yue, Xuetian, et al.
Publicado: (2016)

NKX6.1 Represses Tumorigenesis, Metastasis, and Chemoresistance in Colorectal Cancer
por: Chung, Hsin-Hua, et al.
Publicado: (2020)

HPV-mediated nuclear export of HP1γ drives cervical tumorigenesis by downregulation of p53
por: Yi, Sang Ah, et al.
Publicado: (2020)

Role of the JNK Pathway in Bladder Cancer
por: Lee, Eun Hye, et al.
Publicado: (2022)

Vasohibin 2 Decreases the Cisplatin Sensitivity of Hepatocarcinoma Cell Line by Downregulating p53
por: Li, Zhanjun, et al.
Publicado: (2014)

USP14 promotes colorectal cancer progression by targeting JNK for stabilization
por: Du, Xue-Hua, et al.
Publicado: (2023)

Forkhead Box R2 Knockdown Decreases Chemoresistance to Cisplatin via MYC Pathway in Bladder Cancer
por: Li, Yangle, et al.
Publicado: (2019)

Pleiotrophin promotes chemoresistance to doxorubicin in osteosarcoma by upregulating P-glycoprotein
por: Wu, Dapeng, et al.
Publicado: (2017)

Connexin 32 downregulation is critical for chemoresistance in oxaliplatin-resistant HCC cells associated with EMT
por: Yang, Yan, et al.
Publicado: (2019)

OIP5 Promotes Growth, Metastasis and Chemoresistance to Cisplatin in Bladder Cancer Cells
por: Wang, Dailian, et al.
Publicado: (2018)

Inhibition of SND1 overcomes chemoresistance in bladder cancer cells by promoting ferroptosis
por: Zhao, Yu, et al.
Publicado: (2022)

RGS6 is an essential tumor suppressor that prevents bladder carcinogenesis by promoting p53 activation and DNMT1 downregulation
por: Yang, Jianqi, et al.
Publicado: (2016)

Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis
por: Lee, Jong-Ho, et al.
Publicado: (2017)

The Multiple Roles of Glucose-6-Phosphate Dehydrogenase in Tumorigenesis and Cancer Chemoresistance
por: Song, Jiaqi, et al.
Publicado: (2022)

Downregulating Serine Hydroxymethyltransferase 2 Deteriorates Hepatic Ischemia-Reperfusion Injury through ROS/JNK/P53 Signaling in Mice
por: Wu, Hao, et al.
Publicado: (2019)

Long non-coding RNA ENST00000500843 is downregulated and promotes chemoresistance to paclitaxel in lung adenocarcinoma
por: Tian, Xin, et al.
Publicado: (2019)

Notch signals modulate lgl mediated tumorigenesis by the activation of JNK signaling
por: Paul, Maimuna Sali, et al.
Publicado: (2018)

C23 promotes tumorigenesis via suppressing p53 activity
por: Li, Qun, et al.
Publicado: (2016)

Genetic inhibition of autophagy promotes p53 loss-of-heterozygosity and tumorigenesis
por: Lee, Eunmyong, et al.
Publicado: (2016)

Gut microbiome alters functions of mutant p53 to promote tumorigenesis
por: Lau, Harry Cheuk Hay, et al.
Publicado: (2020)

The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP
por: Zhu, Xiaolin, et al.
Publicado: (2021)

Exosomal miRNA-205 promotes breast cancer chemoresistance and tumorigenesis through E2F1
por: Zhao, Yan, et al.
Publicado: (2021)

Ginsenoside Rh1 Alleviates HK-2 Apoptosis by Inhibiting ROS and the JNK/p53 Pathways
por: Yang, Qi, et al.
Publicado: (2020)

Downregulation of HDGF inhibits the tumorigenesis of bladder cancer cells by inactivating the PI3K-AKT signaling pathway
por: Zhang, Cong, et al.
Publicado: (2019)

Thyrotroph embryonic factor is downregulated in bladder cancer and suppresses proliferation and tumorigenesis via the AKT/FOXOs signalling pathway
por: Yang, Jianan, et al.
Publicado: (2018)

Thrombomodulin expression regulates tumorigenesis in bladder cancer
por: Wu, Chun-Te, et al.
Publicado: (2014)

ASXL1 promotes adrenocortical carcinoma and is associated with chemoresistance to EDP regimen
por: Wang, Liang, et al.
Publicado: (2021)

The deubiquitylase OTUD3 stabilizes GRP78 and promotes lung tumorigenesis
por: Du, Tongde, et al.
Publicado: (2019)

JNK suppression of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic cancer stem cells
por: Suzuki, Shuhei, et al.
Publicado: (2014)

STEAP1 Regulates Tumorigenesis and Chemoresistance During Peritoneal Metastasis of Gastric Cancer
por: Wu, Yuan-Yu, et al.
Publicado: (2018)

STUB1 suppresseses tumorigenesis and chemoresistance through antagonizing YAP1 signaling
por: Tang, Dong‐E, et al.
Publicado: (2019)

The human vault RNA enhances tumorigenesis and chemoresistance through the lysosome in hepatocellular carcinoma
por: Ferro, Iolanda, et al.
Publicado: (2021)

Downregulation of TFAM inhibits the tumorigenesis of non-small cell lung cancer by activating ROS-mediated JNK/p38MAPK signaling and reducing cellular bioenergetics
por: Xie, Deyao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_anhbaacq20cs0ms5ba791eeuja